We induced type 1 diabetes in INK-ATTAC transgenic mice, a mouse model that allows the selective suicide gene-mediated ablation of highly p16-expressing cells upon administration of the drug AP20187 [9]. Here, CDKN2A is linked to type 1 diabetes mellitus.